Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study.

Ageno, Walter; De Candia, Erica; Iacoviello, Licia; Di Castelnuovo, Augusto

Ageno, Walter; De Candia, Erica; Iacoviello, Licia; Di Castelnuovo, Augusto.

Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: walter.ageno@uninsubria.it.
De Candia E; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
Iacoviello L; Department of Medicine and Surgery, University of Insubria, Varese, Italy; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, IS, Italy.
Di Castelnuovo A; Mediterranea Cardiocentro, Napoli, Italy.

Thromb Res ; 203: 138-141, 2021 07.

Article in English | MEDLINE | ID: covidwho-1230796

Subject(s)

Atrial Fibrillation; COVID-19; Stroke; Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Humans; Propensity Score; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Thromb Res Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google